Motor excitability during movement preparation in Tourette syndrome.

Draper A, Jude L, Jackson GM, Jackson SR.

J Neuropsychol. 2015 Mar;9(1):33-44. doi: 10.1111/jnp.12033.

Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.

Abi-Jaoude E, Segura B, Obeso I, Cho SS, Houle S, Lang AE, Rusjan P, Sandor P, Strafella AP.

Hum Brain Mapp. 2015 Jul;36(7):2592-601. doi: 10.1002/hbm.22793.

Population prevalence of Tourette syndrome: a systematic review and meta-analysis.

Scharf JM, Miller LL, Gauvin CA, Alabiso J, Mathews CA, Ben-Shlomo Y.

Mov Disord. 2015 Feb;30(2):221-8. doi: 10.1002/mds.26089. Review.

Association between Tourette syndrome and the dopamine D3 receptor gene rs6280.

He F, Zheng Y, Huang HH, Cheng YH, Wang CY.

Chin Med J (Engl). 2015 Mar 5;128(5):654-8. doi: 10.4103/0366-6999.151665.

Five-months-postoperative neuropsychological outcome from a pilot prospective randomized clinical trial of thalamic deep brain stimulation for Tourette syndrome.

Schoenberg MR, Maddux BN, Riley DE, Whitney CM, Ogrocki PK, Gould D, Maciunas RJ.

Neuromodulation. 2015 Feb;18(2):97-104. doi: 10.1111/ner.12233.

Cognitive Flexibility and Social Responsiveness in Children and Adolescents with Tourette Syndrome.

Güler AS, Berkem M, Yazgan Y, Kalaça S.

Child Psychiatry Hum Dev. 2015 Dec;46(6):940-50. doi: 10.1007/s10578-015-0533-3.

Mindfulness-based stress reduction for Tourette Syndrome and Chronic Tic Disorder: a pilot study.

Reese HE, Vallejo Z, Rasmussen J, Crowe K, Rosenfield E, Wilhelm S.

J Psychosom Res. 2015 Mar;78(3):293-8. doi: 10.1016/j.jpsychores.2014.08.001.

Association study of the SLITRK5 gene and Tourette syndrome.

Zhang K, Feng Y, Wigg KG, Sandor P, Barr CL.

Psychiatr Genet. 2015 Feb;25(1):31-4. doi: 10.1097/YPG.0000000000000067.

Tourette Syndrome research highlights 2014.

Richards CA, Black KJ.

Version 2. F1000Res. 2015 Mar 16 [revised 2015 Jan 1];4:69. doi: 10.12688/f1000research.6209.2.

Tourette Syndrome: Complementary Insights from Measures of Cognitive Control, Eyeblink Rate, and Pupil Diameter.

Tharp JA, Wendelken C, Mathews CA, Marco EJ, Schreier H, Bunge SA.

Front Psychiatry. 2015 Jun 29;6:95. doi: 10.3389/fpsyt.2015.00095.

Gilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies.

Sühs KW, Skripuletz T, Pul R, Alvermann S, Schwenkenbecher P, Stangel M, Müller-Vahl K.

Mol Brain. 2015 Oct 13;8(1):62. doi: 10.1186/s13041-015-0154-6.

Are there distinct subtypes in Tourette syndrome? Pure-Tourette syndrome versus Tourette syndrome-plus, and simple versus complex tics.

Eapen V, Robertson MM.

Neuropsychiatr Dis Treat. 2015 Jun 11;11:1431-6. doi: 10.2147/NDT.S72284.

A personal 35 year perspective on Gilles de la Tourette syndrome: assessment, investigations, and management.

Robertson MM.

Lancet Psychiatry. 2015 Jan;2(1):88-104. doi: 10.1016/S2215-0366(14)00133-3. Review. Erratum in: Lancet Psychiatry. 2015 Apr;2(4):291.

Advances in Tourette syndrome: diagnoses and treatment.

Serajee FJ, Mahbubul Huq AH.

Pediatr Clin North Am. 2015 Jun;62(3):687-701. doi: 10.1016/j.pcl.2015.03.007. Review.

Premonitory Urges in Patients with Gilles de la Tourette Syndrome: An Italian Translation and a 7-Year Follow-up.

Gulisano M, Calì P, Palermo F, Robertson M, Rizzo R.

J Child Adolesc Psychopharmacol. 2015 Dec;25(10):810-6. doi: 10.1089/cap.2014.0154.